Multidrug resistance in leukaemia

British Journal of Haematology

Volumn 96, Issue 4, 1997, Pages 659-674

  McKenna, Sharon L ^a   Padua, Rose Ann ^b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

leukaemia; mammalian cell lines; multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; LEUKEMIA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVIEW;

EID: 0031049802     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2095.x     Document Type: Review

References (203)

1. Ali-Osman, F., Berger, M.S., Rajagopal, S., Spence, A. & Livingstone, R.B. (1995) Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Cancer Research, 53, 5663-5668.
2. Baines, P., Cumber, P. & Padua, R.A. (1992) Multidrug resistance in leukaemia. Bailliere's Clinical Haematology, 5, 943-960.
3. Barrand, M.A., Rhodes, T., Cente, M.S. & Twentyman, P.R. (1993) Chemosensitisation and drug accumulation effects of cyclosporin A. PSC-833 and verapamil in human MDR large cell lung cancer cells expressimg a 190kDa membrane protein distinct from P-glycoprotein. European Journal of Cancer, 29A, 408-415.
4. Batist, G., Tulpule, A., Sinha, B.K., Katki, A.G., Meyers, C.E. & Cowan, K.H. (1986) Overexpression of a novel anionic glutathione transferase in multidnig-resistant human breast cancer cells. Journal of Biological Chemistry, 261, 15544-15549.
5. Beck, J., Niethammer, D. & Gekeler, V. (1996) MDR1,MRP, topoisomerase IIα/β, and cyclin A gene expression in acute and chronic leukemias. Leukemia, 10, (Suppl. 3), S39-S45.
6. Begleiter, A., Lee, K., Israels, L.C., Mowat, M.R.A. & Johnstone, J.B. (1994) Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia, 8, (Suppl. 1), S103-S106.
7. Bertrand, R., Kerrigan, D., Sarang, M. & Pommier, Y. (1991) Cell death induced by topoisomerase II inhibitors: role of calcium in mammalian cells. Biochemical Pharmacology, 42, 77-85.
8. Binaschi, M., Giaccone, G., Gazdar, A.F., DeIsabella, P., Astaldi Ricotti, G.C.B., Capranico, C. & Zunino, F. (1992) Characterization of a topoisomerase II gene rearrangement in a human small cell lung cancer cell line. Journal of the National Cancer Institute, 84, 1710-1716.
9. Black, S.M., Beggs, J.D., Hayes, J.D., Bartoszek, A., Muramatsu, M., Sakai, S. & Wolf, C.R. (1990) Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochemical Journal, 268, 309-315.
10. Brown, G.A., McPherson, J.P., Gu, L., Hedley, D.W., Toso, R., Deuchars, K.L., Freedman, M.H. & Goldenberg, G.J. (1995) Relationship of DNA topoisomerase II α and β expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Cancer Research, 55, 78-82.
11. Broxterman, H.J., Sonneveld, P., Feller, N., Ossenkoppele, G.J., Wahrer, D.C.R., Eekman, C.A., Schoester, M., Lankelma, J., Pinedo, H.M., Lowenberg, B. & Schuurhuis, G.J. (1996) Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood, 87, 4804-4816.
12. Bugg, B.Y., Danks, M.K., Beck, W.T. & Suttle, D.P. (1991) Expression of a mutant topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide. Proceedings of the National Academy of Sciences of the United States of America, 88, 7654-7658.
13. Burger, H., Nooter, K., Zaman, G.J.R., Sonneveld, P., van Wingerden, K.E., Oostrum, R.G. & Stoter, G. (1994) Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia, 8, 990-997.
14. Calsou, P. & Salles, B. (1995) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemotherapy and Pharmacology, 32, 85-89.
15. Campain, J.A., Slovak, M.L., Schoenlein, P.V., Popescu, N.C., Gottesman, M.M. & Pastan, I. (1995) Acquisition of multiple copies of a mutant topoisomerase II alpha by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines. Somatic Cell Molecular Genetics, 21, 451-471.
16. Campos, L., Rouault, J.-.P., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J.-.P. & Guyotat, D. (1993) High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 81, 3091-3096.
17. Capranico, G., Tinelli, S., Austin, C.A., Fisher, M.L. & Zunino, F. (1992) Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochimica et Biophysica Acta, 1132, 43-48.
18. Chan, V.T.W., Ng, S.W., Eder, J.P. & Schnipper, L.E. (1995) Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line. Journal of Biological Chemistry, 268, 2160-2165.
19. Chapman, R.S., Whetton, A.D. & Dive, C. (1994) The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase. Cancer Research, 54, 5137-5137.
20. Chaudhary, P.M., Mechetner, E.B. & Ronison, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735-2739.
21. Chaudhary, P.M. & Ronison, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94.
22. Chen, A.Y. & Liu, L.F. (1994) DNA topoisomerases: essential enzymes and lethal targets. Annual Review of Pharmacology and Toxicology, 34, 191-218.
23. Chen, M. & Beck, W.T. (1995) DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines. Oncology Research, 7, 103-111.
24. Childs, S. & Ling, V. (1994) The MDR superfamily of genes and its biological implications. Important Advances in Oncology (ed. by V. DeVita, S. Hellman and S. A. Rosenberg), pp. 21-36. J. B. Lippincott Company, Philadelphia.
25. Chow, K.C., King, C.K. & Ross, W.E. (1988) Abrogation of etoposide-mediated cytotoxicity by cycloheximide. Biochemical Pharmacology. 37, 1117-1122.
26. Chow, K.C. & Ross, W.E. (1987) Topoisomerase specific drug sensitivity in relation to cell cycle progression. Molecular and Cellular Biology, 7, 3119-3123.
27. Chugani, D.C., Rome, L.H. & Kedersha, N.L. (1993) Evidence that vault ribonucleoprotein particles localise to the nuclear pore complex. Journal of Cell Science, 106, 23-29.
28. Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Makie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M.V. & Deeley, R.G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
29. Coustan-Smith, K., Kitanaka, A., Pui, C.-.H., McNinch, L., Evans, W.E., Raimondi, S.C., Behm, F.G., Arico, M. & Campana, D. (1996) Clinical relevance of BCL-2 over-expression in childhood acute lymphoblastic leukemia. Blood, 87, 1140-1146.
30. Cumber, P.M., Jacobs, A., Hoy, T., Whittaker, J.A., Tsuruo, T. & Padua, R.A. (1991) Increased drug accumulation ex vivo with cyclosporin in chronic lymphocytic leukemia and its relationship to epitope masking of P-glycoprotein. Leukemia, 5, 1050-1053.
31. Danks, M.K., Warmoth, M.R., Friche, K., Granzen, B., Bugg, B.Y., Harker, W.G., Zwelling, L.A., Futscher, B.W., Suttle, D.P. & Beck, W.T. (1995) Single-strand conformational polymorphism analysis of the Mr 170.000 isoenzyme of DNA topoisomerase II in human tumor cells. Cancer Research, 53, 1375-1379.
32. Darkin-Rattray, S.J. & Ralph, R.K. (1991) Evidence that a protein kinase enhances amsacrine mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei. Biochimica et Biophysica Acta, 1088, 285-291.
33. Deffie, A.M., Batra, J.K. & Goldenberg, G.J. (1989a) Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin sensitive and resistant P388 leukemia cell lines. Cancer Research, 49, 58-62.
34. Deffie, A.M., Bosman, D.J. & Goldenberg, G.J. (1989b) Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells. Cancer Research, 49, 6879-6882.
35. de Jong, S., Kooistra, A.J., de Vries, E.G.E., Mulder, N.H. & Zijistra, J.C. (1995) Topoisomerase II as a target of VM-26 and 4-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells. Cancer Research, 53, 1064-1071.
36. Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S. & Papa, G. (1996) Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 1997-2004.
37. Deng, G. & Deisseroth, A.B. (1995) Bcl-x long isoform protects cells from apoptotic cell death expressed in poor prognosis subsets of AML, while Bcl-x short, which promotes cell death is expressed In good prognosis subsets of acute myelogenous leukaemia (AML). (Abstract). Blood, 86, 2342.
38. Dereuddre, S., Frey, S., Delaporte, C. & Jacquemin-Sablon, A. (1995) Cloning and characterization of full length cDNAs coding for the DNA topoisomerase II beta from Chinese hamster lung cells sensitive and resistant to 9-OH-ellipticine. Biochimica et Biophysica Acta, 1264, 178-182.
39. DeVore, R.F., Corbett, A.H. & Osheroff, N. (1992) Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4-(9-acridinylamino)-methane-sulfon-m-anisidide. Cancer Research, 52, 2156-2161.
40. Dive, C. & Hickman, J.A. (1991) Drug-target interactions: only the first step in the commitment to a programmed cell death? British Journal of Cancer, 64, 192-196.
41. Dole, M., Nunez, G., Merchant, A.K., Maybaum, J., Rode, C.K., Bloch, C.A. & Castle, V.P. (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Research, 54, 3255-3259.
42. Drach, D., Zhao, S., Drach, J., Mahedevia, R., Gattringer, C., Huber, H. & Andreeff, M. (1992) Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood, 80, 2729-2734.
43. Drake, F.H., Hofmann, G.A., Bartus, H.E. Mattern, M.R., Crooke, S.T. & Mirabelli, C.K. (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 28, 8154-8160.
44. Dynlacht, J.R., Wong, R.S.L., Albrighl, N. & Dewey, W.C. (1994) Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavable complexes. Cancer Research, 54, 4129-4137.
45. Eastman, A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280.
46. Eder, J.P., Chan, V.T., Ng, S.W., Rizvi, N.A., Zacharoulis, S., Teicher, B.A. & Schnipper, L.E. (1995) DNA topoisomerase II alpha expression is associated with alkylating agent resistance. Cancer Research, 55, 6109-6116.
47. Eder, J.P., Chan, V.T.W., Niemierko, E., Teicher, B.A. & Schnipper, L.E. (1993) Conditional expression of wild type topoisomerase II complements a mutant enzyme in mammalian cells. Journal of Biological Chemistry, 268, 13844-13849.
48. Eder, J.P., Teicher, B.A., Holden, S.A., Cathcart, K.N.S., Schnipper, L.E. & Frei, E., III (1989) Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents. Cancer Research, 49, 595-598.
49. Eder, J.P., Teicher, B.A., Holden, S.A., Senator, L., Cathcart, K.N.S. & Schnipper, L.E. (1990) Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline. Cancer Chemotherapy and Pharmacology, 26, 423-428.
50. El Rouby, S., Thomas, A., Costin, D., Rosenberg, C.R., Potmesil, M., Silber, R. & Newcomb, E.W. (1993) p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood. 82, 3452-3459.
51. Estey, E., Adlakha, R.C., Hittleman, W.N. & Zwelling, L.A. (1987) Cell cycle stage dependent variations in drug induced topoisomerase II mediated DNA cleavage and cytotoxicity. Biochemistry, 26, 4338-4344.
52. Fenaux, P., Jonveaux, P., Quiquandon, I., Lai, J.L., Pignon, J.M., Loucheux-Lefebvre, M.H., Bauters, F., Berger, R. & Kerckaert, J.P. (1991) p53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood, 78, 1652-1657.
53. Fenaux, P., Preudhomme, C., Lai, J.L., Quiquandon, I., Jonveaux, P.H., Vanrumbeke, M., Sartiaux, C., Morel, P., Loucheux-Lefebvre, M.H., Bauters, F., Berger, R. & Kerckaert, J.P. (1992) Mutations of the p53 gene in B-cell chronic lymphocylic leukemia: a report on 39 cases with cytogenic analysis. Leukemia, 6, 246-250.
54. Ferguson, P.J., Fisher, M.H., Stephenson, J., Li, D-h., Zhou, B-s. & Cheng, Y-c. (1988) Combined modalities of resistance in etoposide-resistant human KB cell lines. Cancer Research, 48, 5956-5964.
55. Flens, M.J., Izquierdo, M.A., Scheffer, G.L., Fritz, J.M., Meijer, C.J.L., Scheper, R.J. & Zaman, G.J.R. (1994) Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug resistant tumor cells by monoclonal antibodies. Cancer Research, 54, 4557-4563.
56. Fox, M. & Roberts, J.J. (1987) Drug resistance and DNA repair. Cancer and Metastasis Reviews, 6, 261-281.
57. Frankfurt, O.S., Byrnes, J.J., Seckinger, D. & Sugarbaker, E.V. (1993) Apoptosis (programmed cell death) and the evaluation of chemosensitivity in chronic lymphocytic leukemia and lymphoma. Oncology Research, 5, 37-42.
58. Friesen, C., Herr, I., Krammer, P.H. & Debatin, K.M. (1996) Involvement of the CD95(APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukaemia cells. Nature Medicine, 2, 574-577.
59. Fry, A.M., Chresta, C.M., Davies, S.M., Walker, C. Harris, A.L., Hartley, J.A., Masters, J.R.W. & Hickson, I.D. (1991) Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Research, 51, 6592-6595.
60. Fujiwara, T., Grimm, E.A., Mukhopadhyay, T., Zhang, W.-.W., Owen-Schaub, L.B. & Roth, J.A. (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild type p53 gene. Cancer Research, 54, 2287-2291.
61. Gaidano, G., Ballerini, P., Gong, J., Inghirami, G., Neri, A., Newcomb, E., Magrath, I., Knowles, D. & Della Favera, R. (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 88, 5413-5417.
62. Gekeler, V., Frese, G., Noller, A., Handgretinger, R., Wilisch, A., Schmidt, H., Muller, C.P., Dopfer, R., Klingebiel, T., Diddins, H., Probst, H. & Neithammer, D. (1992) MDR1/P-glycoprotein, topoisomerase and glutathione-s-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. British Journal of Cancer, 66, 507-517.
63. Giaccone, G., Gazdar, A.F., Beck, H., Zunino, F. & Capranico, G. (1992) Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Research, 52, 1666-1674.
64. Gieseler, F., Glasmacher, A., Kampfe, D., Wandt, H., Nuessler, V., Valsamas, S., Kunze, J. & Wilms, K. (1996) Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia, 10, (Suppl. 3), S46-S49.
65. Goasguen, J.E., Dossot, J.M., Fardel, O., LeMee, F., LeGall, E., Leblay, R., LePrise, P.Y., Chaperon, J. & Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394-2398.
66. Godwin, A.K., Meister, A., O'Dwyer, P.J., Huang, C.S., Hamilton, T.C. & Anderson, M.E. (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proceedings of the National Academy of Sciences of the United States of America, 89, 3070-3074.
67. Gottesman, M.M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385-427.
68. Grant, C.E., Valdimarsson, G., Hipfner, D.R., Almquist, K.C., Cole, S.P.C. & Deeley, R.G. (1994) Overexpression of multidrug resistance associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 54, 357-361.
69. Gros, P., Ben Neriah, Y., Croop, J.M. & Housman, D.E. (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 323, 728-731.
70. Gudkov, A.V., Zelnick, C.R., Kazarov, A,R., Thimmapaya, R., Suttle, D.P., Beck, W.T. & Roninson, I.B. (1993) Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proceedings of the National Academy of Sciences of the United States of America, 90, 3231-3235.
71. Guerci, A., Merlin, J.L., Missoum, N., Feldmann, L., Marchai, S., Witz, F., Rose, C. & Guerci, O. (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 85, 2147-2153.
72. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. & Reed, J.C. (1993) Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820-1828.
73. Harker, W.G., Knight, C., Slade, D.L., Kapoor, R. & Parr, R. (1992) Reduced topoisomerase II activity in human CEM leukemia cells selected for resistance tu mitoxantrone. Proceedings of the American Association for Cancer Research, 33, 452 (abstract 2698).
74. Harker, W.G., Slade, D.L., Drake, F.H. & Parr, R.I., (1991) Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase IIβ isoform. Biochemistry, 30, 9955-9961.
75. Harker, W.G., Slade, D.L., Parr, R.L. & Holguin, M.H. (1995) Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 cells selected for resistance to mitoxantrone. Cancer Research, 55, 4962-4971.
76. Hart, S.M., Ganeshaguru, A.V., Hoffbrand, H.G., Prentice, H.G. & Mehta, A.B. (1994) Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Leukemia, 8, 2163-2168.
77. Hashimoto, S., Danks, M.K., Chatterjee, S., Beck, W.T. & Berger, N.A. (1995) A novel point mutation in the 5 Hanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents. Oncology Research, 7, 21-29.
78. Hayes, I.D. & Wolf, C.R. (1988) Role of glutathione transferases and drug resistance. Glutathione Conjugation: Mechanisms and Biological Significance (ed. by H. Sies and B. Ketterer). pp. 315-555. Academic Press, New York.
79. Hegewish-Becker, S. (1996) MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype. Leukemia, 10, (Suppl. 3), S32-S38.
80. Herweijer, H., Sonneveld, P., Baas, F. & Nooter, K. (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemia and association with stimulation of drug accumulation by cyclosporin. Journal of the National Cancer Institute, 82, 1133-1140.
81. Higgins, C.F. (1992) ABC transporters from microorganisms to man. Annual Review of Cell Biology, 8, 67-113.
82. Hinds, M., Deisseroth, K., Mayes, J., Altschuler, E., Jansen, R., Ledley, F.D. & Zwelling, L.A. (1991) Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Cancer Research, 51, 4729-4731.
83. Hoban, P.R., Robson, C.N., Davies, S.M., Hall, A.G., Cattan, A.R., Hickson, I.D. & Harris, A.L. (1992) Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. Biochemical Pharmacology, 43, 685-693.
84. Holden, J.A., Rolfson, D.H. & Wittwer, C.T. (1992) The distribution of immunoreactive topoisomerase II protein in human tissues and neoplasms. Oncology Research, 4, 157-166.
85. Holm, C., Covey, J.M., Kerrigan, D. & Pommier, Y. (1989) Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Research, 49, 6365-6368.
86. Holmes, J.A., Jacobs, A., Carter, G., Whittaker, J.A., Bentley, D.P. & Padua, R.A. (1990a) Is the mdr1 gene relevant in chronic lymphocytic leukemia? Leukemia, 4, 216-218.
87. Holmes, J.A., Wareing, C., Jacobs, A., Hayes, J., Padua, R.A. & Wolf, C.R. (1990b) Glutathione-S-transferase pi expression in leukaemia: a comparative analysis with mdr1 data. British Journal of Cancer, 62, 209-212.
88. Holmes, J.A. & West, R.R. (1994) The effect of MDR1 gene expression on outcome in acute myeloblastic leukaemia. British Journal of Cancer, 69, 382-384.
89. Holmes, J.A., Whittaker, J.A. & Padua, R.A. (1992) Effect of position 185 mutations of the mdr-1 gene on drug resistance in leukemia. Leukemia, 6, 484-485.
90. Imamura, J., Miyoshi, I. & Koeftler, K.P. (1994) p53 in hematologic malignancies. Blood, 84, 2412-2421.
91. Ino, T., Miyazaki, H., Isogai, M., Nomura, T., Tsuzuki, M., Tsuruo, T., Ezaki, K. & Hirano, M. (1994) Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome. Leukemia, 8, 1492-1497.
92. Ishikawa, H., Kawano, M.M., Okaka, K., Tanaka, H., Tanabe, O., Sakai, S., Asaoku, H., Iwato, K., Nobuyoshi, M. & Kuramoto, A. (1993) Expressions of DNA topoisomerase I and II genes and the genes possibly related to drug resistance in human myeloma cells. British Journal of Haematology, 83, 68-74.
93. Ishikawa, T. (1992) The ATP-dependent glutathione S-conjugate export pump. Trends in Biochemical Science, 17, 463-468.
94. Ishikawa, T. (1994) 'GS-X pump' is functionally overexpressed in cisplatin-resistant human leukemia cells. Proceedings of the American Association for Cancer Research, 35, 576 (abstract 2239).
95. Ito, Y., Tanimoto, M., Kumazawa, T., Okumura, M., Morishima, Y., Ohno, R. & Saito, H. (1989) Increased P-glycoprotein expression and multidrug resistance gene (mdr1) amplification are infrequently found in fresh acute leukaemia cells. Cancer, 63, 1534-1538.
96. Izquierdo, M.A., Shoemaker, R.H., Flens, M.J., Scheffer, G.L., Wu, L., Prather, T.R. & Scheper, R.J. (1996) Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. International Journal of Cancer, 65, 230-237.
97. Jenkins, J.R., Ayton, P., Jones, T., Davies, S.L., Simmons, D.L., Harris, A.L., Sheer, D. & Hickson, I.D. (1992) Isolation of cDNA clones encoding the beta isoenzyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Research, 20, 5587-5592.
98. Jiang, X.-R., Kelsey, S.M., Wu, Y.-L. & Newland, A.C. (1995) Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833. British Journal of Haematology, 90, 375-383.
99. Juliano, R.L. & Ling, V. (1976) A surface glycoprotein modulating , drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta, 455, 152-162.
100. Kampinga, H.H., Kruk, G. v.d. & Konings, A.W.T. (1989) Reduced DNA break formation and cytotoxicity of the topoisomerase II drug 4-(9-acridinylamino)methanesulfon-m-anisidide when combined with hyperthermia in human and rodent cell lines. Cancer Research, 49, 1712-1717.
101. Kato, S., Ideguchi, H., Muta, K., Nishimura, J. & Nawata, H. (1991) Absence of correlation between cytotoxicity and drug transport by P-glycoprotein in clinical leukaemic cells. European Journal of Haematoloay, 47, 146-151.
102. Kaufmann, S. (1992) Factors affecting the sensitivity of human leukemia cells to topoisomerase II-directed agents. Proceedings, 4th Conference on DNA Topoisomerases in Therapy abstract 43.
103. Kaufmann, S.H., Karp, J.E., Jones, R.J., Miller, C.B., Schneider, E., Zwelling, L.A., Cowan, K., Wendel, K. & Burke, P.J. (1994) Topoisomerase II levels and drug sensitivity in adult myelogenous leukemia. Blood, 83, 517-530.
104. Keith, F.J., Bradbury, D.A., Zhu, Y.-M. & Russell, N.H. (1995) Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and Increases sensitivity of AML blasts to Ara-C. Leukemia, 9, 131-138.
105. Kellen, J.A. (1993) The reversal of multidrug resistance in cancer. Anticancer Research, 13, 959-961.
106. Khelifa, T., Casabianca-Pignede, M.-.R., Rene, B. & Jacquemin-Sablon, A. (1994) Expression of topoisomerase II α and β in Chinese hamster lung cells resistant to topoisomerase II inhibitors. Molecular Pharmacology, 46, 323-328.
107. Kim, R. & Beck, W.T. (1994) Differences between drug sensitive and resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of jun/fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Cancer Research, 54, 4958-4966.
108. Kimura, K., Saijo, M., Ui, M. & Enomoto, T. (1994) Growth state and cell cycle dependant fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase. Journal of Biological Chemistry, 269, 1173-1176.
109. Kramer, R.A., Zakher, J. & Kim, G. (1988) Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science, 241, 694-697.
110. Krishnamachary, N. & Center, M.S. (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Research, 53, 3658-3661.
111. Kupfer, G., Bodley, A.L. & Liu, L.F. (1987) Involvement of intracellular ATP in cytotoxicity of topoisomerase II targeting antitumor drugs. NCI Monographs, 4, 37-40.
112. Kuwazuru, Y., Yoshimura, A., Hanada, S., Ichikawa, M., Saito, T., Uozumi, K., Utsunomiya, A., Arima, T. & Akiyama, S.-I. (1990) Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis. British Journal of Haematology, 74, 24-29.
113. Lee, F.Y.F., Flannery, D.J. & Siemann, D.W. (1992) Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4-hydroperoxycyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase II. Cancer Research, 52, 3515-3520.
114. Lee, M.S., Wang, J.C. & Beran, M. (1992) Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170kDa form of human topoisomerase II. Journal of Molecular Biology, 223, 837-843.
115. Leier, I., fetlitschky, G., Buchholz, U. & Keppler, D. (1994) Characterization of the ATP-dependant leukotriene C4 export carrier in mastocytoma cells. European Journal of Biochemistry 220, 599-606.
116. Leyland-Jones, B.R., Townsend, A.J., Tu, C.P.D., Cowan, K.H. & Goldsmith, M.E. (1991) Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene. Cancer Research, 51, 587-594.
117. Ling, Y.-.H., Priebe, W. & Perez-Soler, R. (1993) Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Research, 53, 1845-1852.
118. List, A.F. (1996) The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia, 10, (Suppl. 2), S46-S51.
119. List, A.F., Spier, C.S., Grogan, T.M., Johnson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J. & Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 2464-2469.
120. Long, B.H., Musial, S.T. & Brattain, M.G. (1985) Single- and double-strand DNA breaks and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Research, 45, 3106-3112.
121. Lorico, A., Toffoli, G. & Biocchi, M. (1988) Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Research, 48, 2036-2041.
122. Markovits, J., Pommier, Y., Kerrigan, D., Covey, J.M., Tilchen, E.J. & Kohn, K.W. (1987) Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 tibroblasts and L1210 leukemia cells. Cancer Research, 47, 2050-2055.
123. Marks, D.I. & Fox, R.M. (1991) DNA damage, poly (ADP-ribosyl)-ation and apoptotic cell death as a potential common pathway of cytotoxic drug action. Biochemical Pharmacology, 42, 1859-1867.
124. Martin, S.J. & Cotter, T.G. (1990) Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL-60 cells. Cell and Tissue Kinetics, 23, 545-559.
125. Mattern, M.R. & Scudiero, D.A. (1981) Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid. Biochimica et Biophysica Acta, 653, 248-258.
126. Maung, Z.T., MacLean, F.R., Reid, M.M., Pearson, A.D.J., Proctor, S.J., Hamilton, P.J. & Hall, A.G. (1994) The relationship between bcl-2 expression and response to therapy in acute leukaemia. British Journal of Haematology, 88, 105-109.
127. McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K.M., Green, D.R. & Cotter, T.G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1187.
128. McKenna, S.L. & Cotter, T.G. (1997) Functional aspects of apoptosis in haematopoiesis and consequences of failure. Advances in Cancer Research, in press.
129. McKenna, S.L., West, R.R., Whittaker, J.A., Padua, R.A. & Holmes, J.A. (1994) Topoisomerase II alpha expression in acute myeloid leukemia and its relationship to clinical outcome. Leukemia, 8, 1498-1502.
130. McKenna, S.L., Whittaker, J.A., Padua, R.A. & Holmes, J.A. (1993) Topoisomerase II expression in normal hemopoietic cells and chronic lymphocytic leukemia: drug sensitivity or resistance? Leukemia, 7, 1199-1203.
131. McPherson, J.P., Brown, G.A. & Goldenberg, G.J. (1993) Characterization of a DNA topoisomerase IIα gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIα and the retinoic acid receptor α locus. Cancer Research, 53, 5885-5889.
132. McQuaid, S., McCann, S., Daly, P., Lawlor, E. & Humphries, P. (1989) Observations on the transcriptional activity of the glutathione S-transferase gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy. British Journal of Cancer, 59, 540-543.
133. Mestdagh, N., Pommery, N., Saucier, J.-.M., Hecquet, B., Fournier, C., Slomianny, C., Teissier, E. & Henichart, J.-P. (1994) Chemoresistance to doxorubicin and cisplatin in a murine cell line: analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes. Anticancer Research, 14, 869-874.
134. Minn, A.J., Rudin, C.M., Boise, L.H. & Thompson, C.B. (1995) Expression of Bcl-x can confer a multidrug resistance phenotype. Blood, 86, 1903-1910.
135. Mirski, S.E.L. & Cole, S.P.C. (1994) A 3 deletion in topoisomerase IIα mRNA is associated with VP-16 resistance in a small cell lung cancer cell line. Proceedings of the American Association for Cancer Research, 35, 2700.
136. Morrow, C.S. & Cowan, K.H. (1993) Antineoplastic drug resistance and breast cancer. Annals of the New York Academy of Sciences, 698, 289-312.
137. Moscow, J.A., Fairchild, C.R. & Madden, M.J. (1989) Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Research, 49, 1422-1428.
138. Muller, M., Meijer, C., Zaman, G.J.R., Borst, P., Scheper, R.J., Mulder, N.H., de Vries, E.G.E. & Jansen, P.L.M. (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proceedings of the National Academy of Sciences of the United States of America, 91, 13033-13037.
139. Negri, C., Chiesa, R., Cerino, A., Bestagno, M., Sala, C., Zini, N., Maraldi, N.M. & Astaldi Ricotti, G.C.B. (1992) Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isoenzymes. Experimental Cell Research, 200, 452-459.
140. Nitiss, J.L., Liu, Y.-.X., Harbury, P., Jannatipour, M., Wasserman, R. & Wang, J.C. (1992) Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Cancer Research, 52, 4467-4472.
141. Osheroff, N., Zechiedrich, E.L. & Gale, K.C. (1991) Catalytic function of DNA topoisomerase II. BioEssays, 13, 269-275.
142. Patel, S. & Fisher, L.M. (1993) Novel selection and genetic characterisation of an etoposide resistant human leukaemic CCRF-CEM cell line. British Journal of Cancer, 67, 456-463.
143. Perri, R.T., Louie, S.W. & Espar, W.d. (1989) Expression of the multidrug resistance (MDR) gene mdr1 in chronic lymphocytic leukemia (CLL) B cells. Blood, 74, 198a.
144. Petrov, P., Drake, F.H., Loranger, A., Huang, W. & Hancock, R. (1993) Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Experimental Cell Research, 204, 75-81.
145. Pirker, R., Goldstein, L.J., Ludwig, H., Linkeseh, W., Lechner, C., Gottesman, M.M. & Pastan, I. (1989) Expression of a multidrug resistance gene in blast crisis of chronic myeloid leukaemia. Cancer Communications, 1, 141-144.
146. Pommier, Y. (1995) DNA topoisomerase I and II in cancer chemotherapy: update and perspectives. Cancer Chemotherapy and Pharmacology. 32, 103-108.
147. Pommier, Y., Schwartz, R.E., Khon, K.W. & Zwelling, L.A. (1984) Formation and rejoining of deoxyribonucleic acid double strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents. Biochemistry, 23, 3194-3201.
148. Prosperi, E., Sala, E., Negri, C., Oliani, C., Supino, R., Astaldi Ricotti, G.C.B. & Bottiroli, G. (1992) Topoisomerase II α and β in human tumor cells grown in vitro and in vivo. Anticancer Research, 12, 2093-2100.
149. Puchalski, R.B. & Fahl, W.E. (1990) Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents. Proceedings of the National Academy of Sciences of the United States of America, 87, 2443-2447.
150. Rabier, M.J., Bruno, N.A. & Slate, D.L. (1991) Multifactorial resistance in LS174T human colon carcinoma cells selected with doxorubicin. International Journal of Cancer, 49, 601-607.
151. Ritke, M.K., Allan, W.P., Fattman, C., Gunduz, N.N. & Yalowich, J.C. (1994a) Reduced phosphorylation of topoisomerase II in etoposide resistant human leukaemia K562 cells. Molecular Pharmacology, 46, 58-66.
152. Ritke, M.K., Bergoltz, V.V., Allan, W.P. & Yalowich, J.C. (1994b) Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells. Biochemical Pharmacology, 48, 525-533.
153. Ritke, M.K. & Yalowich, J.C. (1993) Altered gene expression in human leukemia K562 cells selected for resistance to etoposide. Biochemical Pharmacology, 46, 2007-2020.
154. 4. Proceedings of the American Association for Cancer Research, 34, 333 (abstract 1984).
155. Robertson, L.E., Chubb, S., Meyn, R.E., Story, M., Ford, R., Hittelman, W.N. & Plunkett, W. (1995) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine. Blood, 81, 143-150.
156. Robson, C.N., Alexander, J., Harris, A.L. & Hickson, I.D. (1986) Isolation and characterisation of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustards. Cancer Research, 46, 6290-6294.
157. Roninson, I.B., Chin, J.E., Choi, K.G., Gros, P., Housman, D.E., Eojo, A.T., Shen, D.W., Gottesman, M.M. & Pastan, I. (1986) Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America, 83, 4538-4552.
158. Samuels, B.L., Murray, J.L., Cohen, M.B., Safa, A.R., Sinha, B.K., Townsend, A.J., Beckett, M.A. & Weichselbaum, R.R. (1991) Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Research, 51, 521-527.
159. Sato, H., Gottesmari, M.M., Goldstein, L.J., Pastan, I., Block, A.M., Sandberg, A.A. & Preisler, H.D. (1990) Expression of the multidrug resistance gene in myeloid leukemias. Leukemia Research, 14, 11-21.
160. Scheeter, R.L., Aloui-Jamali, M.A., Woo, A., Fahl, W.E. & Batist, G. (1995) Expression of rat glutathione-S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity. Cancer Research, 55, 4900-4906.
161. Scheffer, G.L., Wijngaard, P.L., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M., Meijer, C.J., Clevers, H.C. & Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578-582.
162. Schena, M., Larsson, L.G., Gottardi, D., Gaidano, G., Carlsson, M., Nilsson, K. & Caligaris-Cappio, R (1992) Growth and differention association of bcl-2 in B-chronic lymphocytic leukemia cells. Blood, 79, 2981-2989.
163. Scheper, R.J., Broxterman, H.J., Scheffer, G.L., Kaaijk, P., Dalton, W.S., Van Heijningen, T.H.M., van Kalken, C.K., Slovak, M.L., de Vries, E.G.E., van der Valk, P., Meijer, C.J.L. & Pinedo, H.M. (1995) Overexpression of a Mr110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Research, 53, 1475-1479.
164. Schisselbauer, J.C., Silber, R., Papadopoulos, E., LaCreta, F.P. & Tew, K.D. (1990) Characterisation of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Research, 50, 3562-3568.
165. Schneider, E., Cowan, K.H., Bader, H., Toomey, S., Schwartz, G.N., Karp, J.E., Burke, P.J. & Kaufmannm S.H. (1995) Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood, 85, 186-193.
166. Schneider, E., Lawson, P.A. & Ralph, R.K. (1989) Inhibition of protein synthesis reduces the cytotoxicity of 4-(9-acridinylamino) methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line. Biochemical Pharmacology, 38, 263-269.
167. Shustik, C., Groulx, N. & Gros, P. (1991) Analysis of multidrug resistance (mdr1) gene expression in chronic lymphocytic leukaemia. British Journal of Haematology, 79, 50-56.
168. Slovak, M.L., Ho, J.P., Cole, S.P., Deeley, R.G., Greenberger, L., de Vries, E.G., Broxterman, H.J., Scheffer, G.L. & Scheper, R.J. (1995) The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Research, 55, 4214-4219.
169. Slovak, M.L., Pelkey, H.O.J., Bhardwaj, G., Kurz, E.U., Deeley, R.G. & Cole, S.P.C. (1993) Localization of a novel multidrug resistance associated gene in the HT10H0/DR4 and H69AR human tumor cell lines. Cancer Research, 53, 3221-3225.
170. Snyder, R.D., Van Houten, B. & Regan, J.D. (1982) Studies on the inhibition of repair of ultraviolet and methanesulfonate-induced damage in the DNA of human fibroblasts by novobiocin. Nucleic Acids Research, 10, 6207-6219.
171. Stoetzer, O.J., Nussler, V., Darsow, M., Gullis, E., Pelka-Fleischer, R., Scheel, U. & Wilmanns, W. (1996) Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia, 10, (Suppl. 3), S18-S22.
172. Sumantran, V.N., Ealovega, M.W., Nunez, G., Clarke, M.F. & Wicha, M.S. (1995) Overexpression of bclx-s, a dominant negative inhibitor of bcl-2 sensitizes MCF-7 cells to chemotherapy induced apoptosis. Proceedings of the American Association for Cancer Research, 36, 111.
173. Takano, H., Kohno, K., Ono, M., Uchida, Y. & Kuwano, M. (1991) Increased phosphorylation of DNA topoisomerase II in eloposide-resistant mutants of human cancer KB cells. Cancer Research, 51, 3951-3957.
174. Takano, H., Vilalta, P., Hsiung, Y., Spengler, B.A., Beidler, J.L., Nitiss, J.L. & Fojo, T. (1994) Characterization of intrinsic and acquired mutations in topoisomerase II (topo II). Proceedings of the American Association for Cancer Research, 35, 2181.
175. Tan, K.B., Mattern, M.R., Eng, W.-K., McCabe, F.L. & Johnson, R.K. (1989) Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors, Journal of the National Cancer Institute, 81, 1732-1735.
176. Tan, K.B., Per, S.R., Boyce, R.A., Mirabelli, C.K. & Crooke, S.T. (1988) Altered expression and transcription of the topoisomerase II gene in nitrogen mustard-resistant human cells. Biochemical Pharmacology, 37, 4413-4416.
177. Tew, K.D., Houghton, J.A. & Houghton, P.J. (1993) Preclinical and Clinical Modulation of Anticancer Drugs. CRC Press, Boca Raton, Florida.
178. Tidefelt, U., Elmhorn-Rosenborg, A., Paul, C., Hao, X.-Y., Mannervik, B. & Eriksson, L.C. (1992) Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Research, 52, 3281-3285.
179. Tiirikainen, M.L. Elonen, E., Syrjala, M.T., Jansson, S.-E. & Krusius, T. (1994) Flow cytometric analysis of glutathione-S-transferase pi in acute leukemia, Leukemia, 8, 978-984.
180. Tosi, P., Visani, G., Ottaviani, E., Manfroi, S., Luigi Zinzani, P. & Tura, S. (1994) Fludarabine ARA-C G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells. Leukemia, 8, 2076-2082.
181. Tsuruo, T. & Tomida, A. (1995) Multidrug resistance. Anti-Cancer Drugs, 6, 213-218.
182. Twentyman, P.R. (1992) Cyclosporins as drug resistance modifiers. Biochemical Pharmacology, 43, 109-117.
183. Ueda, K., Cardarelli, C., Gottesman, M.M. & Pastan, I. (1987) Expression of a full length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin and vinblastine. Proceedings of the National Academy of Sciences of the United States of America, 84, 3004-3008.
184. Van der Bliek, A.M., Kooiman, P., Schneider, C. & Borst, P. (1988) Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene, 71, 401-411.
185. Vosberg, H.P. (1985) DNA topoisomerases: enzymes that control DNA conformation. Current Topics in Microbiology and Immunology, 114, 19-102.
186. Walker, P.R., Smith, C., Youdale, T., Leblancm J., Whittield, J.F. & Sikorska, M. (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Research, 51, 1078-1085.
187. Walton, M.I., Whysong, D., O'Connor, P.M., Hockenbery, D., Korsmeyer, S.J. & Kohn, K.W. (1993) Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Research, 53, 1853-1861.
188. Wang, A.L. & Tew, K.D. (1985) Increased glutathione S-transferase activity in a cell line with acuired resistance to nitrogen mustards. Cancer Treatment Reports, 69, 677-682.
189. Wang, J.C. (1985) DNA topoisomerases. Annual Review of Biochemistry, 54, 665-697.
190. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumheke, M., Quesnel, B., Dervite, I., Morel, P. & Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157.
191. Webb, C.D., Latham, M.D., Lock, R.B. & Sullivan, D. (1991) Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. Cancer Research, 51, 6543-6549.
192. White, E. (1996) Life, death, and the pursuit of apoptosis. Genes and Development, 10, 1-15.
193. Withoff, S., Smit, E.F. Meersma, G.J., van den Berg, A., Timmer-Bosscha, H., Kok, K., Postmus, P.E., Mulder, M.H., de Vries, E.G.E. & Buys, C.H.C.M. (1994) Quantitation of DNA topoisomerase IIα messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay. Laboratory Investigation, 71, 61-66.
194. Woessner, R.D., Mattern, M.R., Mirabelli, C.K., Johnson, R.K. & Drake, F.H. (1991) Proliferation and cell cycle dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth and Differentiation, 2, 209-214.
195. Wolverton, J.S. & Beck, W.T. (1990) VM-26-resistant CEM cells display collateral sensitivity to nitrogen mustard, UV irradiation, and 3-amlnobenzamide (abstr.2238). Proceedings of the American Association for Cancer Research, 31, 337.
196. Zaman, G.J.R., Flens, M.J., van Leusden, M.R., de Haas, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J. & Borst, P. (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proceedings of the National Academy of Sciences of the United States of America, 91, 8822-8826.
197. Zaman, G.J.R., Versantvoort, C.H.M., Smit, J.J.M., Eijdems, E.W.H.M., de Haas, M., Smith, A.J., Broxterman, H.J., Mulder, N.H., de Vries, E.G.E., Baas, F. & Borst, P. (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Research, 53, 1747-1750.
198. Zhou, D.C., Zittoun, R. & Marie, J.P. (1995) Expression of multidrug resistance-associated protein (MRP) and multidrug resistance genes in acute myeloid leukemia. Leukemia, 9, 1661-1666.
199. Zini, N., Martelli, A.M., Sabatelli, P., Santi, S., Negri, C., Astaldi Ricotti, G.C.B. & Maraldi, N.M. (1992) The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Experimental Cell Research, 200, 460-466.
200. Zini, N., Santi, S., Ognibene, A., Bavalloni, A., Negri, L.M., Valmori, A., Mariani, E., Negri, C., Astaldi Ricotti, G.C.B. & Maraldi., N.M. (1994) Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Experimental Cell Research, 210, 336-348.
201. Zochbauer, S., Gsur, A., Brunner, R., Kyrie, P.A., Lechner, K. & Pirker, R. (1994) P-glycoprotein expression as an unfavorable prognostic factor in acute myeloid leukemia. Leukemia, 8, 974-977.
202. Zwelling, L.A. (1989) Topoisomerase II as a target of antileukemia drugs: a review of controversial areas. Hematology and Pathology, 3, 101-112.
203. Zwelling, L.A., Michaels, S., Erickson, L.C., Ungerleider, R.S., Nichols, M. & Kohn, K.W. (1981) Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonuclcic acid intercalating agents 4-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Biochemistry, 20, 6553-6563.